Skip to main content
main-content

01.12.2012 | Research | Ausgabe 1/2012 Open Access

Molecular Cancer 1/2012

Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma

Zeitschrift:
Molecular Cancer > Ausgabe 1/2012
Autoren:
Chih-Ming Ho, Chi-Jung Huang, Chia-Yen Huang, Yih-Yiing Wu, Shwu-Fen Chang, Wen-Fang Cheng
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1476-4598-11-53) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no conflicts of interest.

Authors’ contributions

CMH applied for the grant, and conducted the study, and participated in its design and coordination, and draft manuscript. CJH helped molecular analyses and interpretation. CYH performed statistical analysis. YYW performed the pathologic analysis and interpretation. SFC and WFC participated in designing and coordinating of the study and helped draft the manuscript. All authors read and approved the final manuscript.

Abstract

Background

This study is to analyze promoter methylation of various tumor suppressor genes in different types of ovarian carcinoma and to identify potential therapeutic targets of ovarian clear cell adenocarcinoma (OCCA).

Materials and methods

The promoter methylation statuses of 40 genes in primary ovarian carcinomas including 47 clear- and 63 non-clear-cell type tissues, 6 OCCA cell lines, 29 benign ovarian endometriotic cysts, and 31 normal controls were analyzed by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA). The MS-MLPA results were correlated with clinicopathological features and outcomes of 47 OCCA patients. Functions of the target genes were further explored by Western Blot Analysis, apoptosis assay, and caspase-3/7 activity analysis.

Results

Frequencies of methylated RASSF1A, CDH13, CACNA1A, HIN-1, and sFRP5 genes in OCCA tissues were significantly higher than those in non-OCCA cancerous tissues and benign endometriotic cysts. The expected OS for patients with methylated promoters of HIN-1 was significantly worse than those for patients without methylated HIN-1 (30% vs. 62%, p = 0.002). The HIN-1 gene was over-expressed in ES2 cells, a significant reduction in cell growth and induction of apoptosis, and increasing paclitaxel sensitivity by reducing phosphorylation of Akt were observed.

Conclusions

Methylation of HIN-1 promoter is a novel epigenetic biomarker associated with poor outcomes in OCCA patients. Ectopic expression of the HIN-1 gene increased paclitaxel sensitivity which is partly through Akt pathway.
Zusatzmaterial
Authors’ original file for figure 1
12943_2012_1050_MOESM1_ESM.pdf
Authors’ original file for figure 2
12943_2012_1050_MOESM2_ESM.tiff
Authors’ original file for figure 3
12943_2012_1050_MOESM3_ESM.pdf
Authors’ original file for figure 4
12943_2012_1050_MOESM4_ESM.pdf
Authors’ original file for figure 5
12943_2012_1050_MOESM5_ESM.pdf
Authors’ original file for figure 6
12943_2012_1050_MOESM6_ESM.pdf
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

Molecular Cancer 1/2012 Zur Ausgabe

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise